Literature DB >> 2327982

Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 alpha-ethinyloestradiol. Relative activities of rat and human liver enzymes.

S E Ball1, L M Forrester, C R Wolf, D J Back.   

Abstract

The metabolism of oestradiol and 17 alpha-ethinyloestradiol to their 2-hydroxy derivatives is an important determinant in their biological effects. In this work, we have investigated which rat or human cytochrome P-450 isoenzymes are involved in catalysing these reactions. Oestradiol 2-hydroxylation was catalysed by a wide variety of rat cytochrome P-450s from gene families P450IA, P450IIB, P450IIC and P450IIIA. Interestingly, 17 alpha-ethinyloestradiol, which only differs structurally from oestradiol at a position distant from the site of oxidation, was metabolized predominantly by members of the P450IIC gene subfamily. In order to establish which enzymes are responsible for the oxidation of these substrates in man, antibodies to rat liver cytochrome P-450 isoenzymes were used to inhibit these reactions in a panel of human liver microsomal fractions. Also, possible correlations between the proteins recognized by the antibodies and the 2-hydroxylation rate were determined. These experiments provide evidence that 2-hydroxylation of 17 alpha-ethinyloestradiol in man is catalysed by cytochromes from the P450IIC, P450IIE and P450IIIA gene families. In contrast, the major proteins involved in oestradiol metabolism are from the P450IA gene family, although members of the P450IIC and P450IIE gene families may also play a role. These data demonstrate that the differences in the capacity of rat P-450s to metabolize these substrates are also present in the comparable enzymes involved in man, and that a variety of factors will determine the rate of disposition of these compounds in man.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2327982      PMCID: PMC1131267          DOI: 10.1042/bj2670221

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol.

Authors:  I N White; U Muller-Eberhard
Journal:  Biochem J       Date:  1977-07-15       Impact factor: 3.857

Review 3.  Metabolism of estrogens--natural and synthetic.

Authors:  H M Bolt
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

4.  Metabolism of 17 alpha-ethinylestradiol by human liver microsomes in vitro: aromatic hydroxylation and irreversible protein binding of metabolites.

Authors:  H M Bolt; H Kappus; R Käsbohrer
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

5.  Gene structure of a major form of phenobarbital-inducible cytochrome P-450 in rat liver.

Authors:  Y Suwa; Y Mizukami; K Sogawa; Y Fujii-Kuriyama
Journal:  J Biol Chem       Date:  1985-07-05       Impact factor: 5.157

6.  17 beta-estradiol 2- and 4-hydroxylation catalyzed by rat hepatic cytochrome P-450: roles of individual forms, inductive effects, developmental patterns, and alterations by gonadectomy and hormone replacement.

Authors:  G A Dannan; D J Porubek; S D Nelson; D J Waxman; F P Guengerich
Journal:  Endocrinology       Date:  1986-05       Impact factor: 4.736

7.  Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism.

Authors:  F P Guengerich; M V Martin; P H Beaune; P Kremers; T Wolff; D J Waxman
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

8.  Effects of insecticide synergists on microsomal oxidation of estradiol and ethynylestradiol and on microsomal drug metabolism.

Authors:  H M Bolt; H Kassel
Journal:  Xenobiotica       Date:  1976-01       Impact factor: 1.908

9.  Inhibition of estrogen 2-hydroxylase.

Authors:  H S Purba; D J Back; A M Breckenridge
Journal:  J Steroid Biochem       Date:  1986-05       Impact factor: 4.292

10.  The effect of cigarette smoking on 7-ethoxyresorufin O-deethylase and other monooxygenase activities in human liver: analyses with monoclonal antibodies.

Authors:  O Pelkonen; M Pasanen; H Kuha; B Gachalyi; M Kairaluoma; E A Sotaniemi; S S Park; F K Friedman; H V Gelboin
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

View more
  16 in total

Review 1.  St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

Authors:  L Henderson; Q Y Yue; C Bergquist; B Gerden; P Arlett
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

2.  Drug-phytochemical interactions.

Authors:  Costas Ioannides
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

3.  Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes.

Authors:  A P Li; N R Hartman; C Lu; J M Collins; J M Strong
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

Review 4.  Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.

Authors:  Hongjian Zhang; Donghui Cui; Bonnie Wang; Yong-Hae Han; Praveen Balimane; Zheng Yang; Michael Sinz; A David Rodrigues
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

5.  Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.

Authors:  L M Forrester; C J Henderson; M J Glancey; D J Back; B K Park; S E Ball; N R Kitteringham; A W McLaren; J S Miles; P Skett
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

Review 6.  Pharmacokinetic drug interactions with oral contraceptives.

Authors:  D J Back; M L Orme
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 7.  Estradiol valerate/dienogest.

Authors:  Keri Wellington; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  Pharmacodynamics and pharmacokinetics of oral contraceptives co-administered with alosetron (Lotronex).

Authors:  Kevin Koch; Corinne Campanella; Charlotte A Baidoo; Janet A Manzo; Vanessa Z Ameen; Kathryn E E Kersey
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

Review 9.  Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.

Authors:  T Andersson
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

10.  N-demethylation of ethylmorphine in pregnant and non-pregnant women and in men: an evaluation of the effects of sex steroids.

Authors:  E Gerdin; A Rane
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.